University of Napoli Federico II | News Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

541,330 results for “University of Napoli Federico II”

AI-Powered Spatial Biology Platforms Advance Predictive Biomarker Discovery in Cancer Immunotherapy

University of Naples Federico II Launches PharmaTech Academy 2026–2027 for RNA and Gene Therapy Workforce Training

University of Oxford Launches World's First Phase II Nipah Virus Vaccine Trial in Bangladesh

UNITY Biotechnology Appoints Federico Grossi as Chief Medical Officer

NAPOLI 3 Post-Hoc Analysis Identifies Characteristics Associated with Long-Term Survival in Metastatic Pancreatic Cancer

BioCardia Advances Phase 3 CardiAMP HF II Trial with First Patient Enrollment at University of Wisconsin

Stanford University Receives Double-Digit Million NIH Grant for Phase II Trial of Tiprelestat in Pulmonary Arterial Hypertension

Cosmo Completes Phase II Enrollment for Novel Rifamycin Enema in Distal Ulcerative Colitis

Immutep Partners with George Washington University for Phase II Neoadjuvant Breast Cancer Trial

AI-Powered Model Aims to Decode Genetic Variants in Stargardt Disease

Page 1 of 4081